MAPKAPK2 and atrial fibrillation: In addition, the application of 1.0 μM SB203580 for 2 hours significantly blocked 2.0 μM AF-induced the reduction of total EGFR and the increase of phosphorylated EGFR, P38MAPK, MAPKAPK2, and HSP27 (Fig 9).